News

October 12, 2015 2:30 pm
A Randomized, Open-label, Phase III Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib (Kyprolis®) in Combination with Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing
October 12, 2015 2:30 pm
Beth Faiman, PhD, MSN, APRN-BC, AOCN Cleveland Clinic Taussig Cancer Institute Multiple Myeloma Program Cleveland, Ohio Teresa Miceli, RN, BSN, OCN Mayo Clinic-Rochester Rochester, Minnesota
October 12, 2015 2:30 pm
IMF Chairman Dr. Brian Durie recaps the International Myeloma Workshop (IMW) meeting in Rome, where myeloma experts debated, among other questions, whether we are curing myeloma. He also comments on recent news articles investigating the rise of...
October 5, 2015 9:30 am
Dr. Bruno Paiva, a member of IMF's Black Swan Research Initiative team, won the Bart Barlogie Young Investigator Award on Saturday at the International Myeloma Workshop in Rome. Dr. Paiva's primary research area is the assessment of minimal residual...

Pages